Thallion Pharmaceuticals, Inc.

Thallion Pharmaceuticals, Inc.

Sector: Commercial Physical And Biological Research Region: Canada

Similar to: Cerep SA, Exelixis, Inc., Medivir AB

Thallion Pharmaceuticals, Inc. is a biotechnology company focused on developing new pharmaceutical products in the areas of infectious disease and oncology. Its products are Shigamabs, a dual antibody product for the treatment of Shigatoxin-producing E. coli bacterial infections and TLN-4601, a proprietary first in class small molecule with potential efficacy in multiple oncology indications. The company was founded in January 1998 and is headquartered in Dorval, Canada.

News & Analysis

You may also be interested in: